Qianqian Han

Dr. Qianqian Han


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Bio-Design and Manufacturing
Verified
Journal Article
Closed access
PDF file
ZJZhongboyu Jin
Zhongboyu Jin
CHChaofan He
Chaofan He
JFJianzhong Fu
Jianzhong Fu
QHQianqian Han
Qianqian Han
Yong HeYong He
Yong He

3 August 2021 in Bioactive Materials
Verified
Journal Article
Open access
LWLi Wang
Li Wang
XGXiaolei Guo
Xiaolei Guo
JCJiaqing Chen
Jiaqing Chen
ZZZhen Zhen
Zhen Zhen
BCBin Cao
Bin Cao
ZGZigang Ge
Zigang Ge
With the interdisciplinary convergence of biology, medicine and materials science, both research and clinical translation of biomaterials are progressing at a rapid pace. However, there is still a huge gap between applied basic research on biomaterials and their translational products - medical devices, where two significantly different perspectives and mindsets often work independently and non-synergistically, which in turn significantly increases financial costs and research effort. Although this gap is well-known and often criticized in the biopharmaceutical industry, it is gradually widening. In this article, we critically examine the developmental pipeline of biodegradable biomaterials and biomaterial-based medical device products. Then based on clinical needs, market analysis, and relevant regulations, some ideas are proposed to integrate the two different mindsets to guide applied basic research and translation of biomaterial-based products, from the material and technical perspectives. Cartilage repair substitutes are discussed here as an example. Hopefully, this will lay a strong foundation for biomaterial research and clinical translation, while reducing the amount of extra research effort and funding required due to the dissonance between innovative basic research and commercialization pipeline.

7 April 2026 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
YYYu Yao
Yu Yao
XDXuan Du
Xuan Du
YLYanhui Li
Yanhui Li
YMYuchen Ma
Yuchen Ma
YLYuchen Li
Yuchen Li
Zaozao ChenZaozao Chen
Zaozao Chen
Introduction: Abnormal pigmentation plays an important role in various skin diseases and in studies of whitening efficacy.Three-dimensional pigmented epidermis-on-a-chip models provide a crucial in vitro platform for exploring melanin production and regulation in skin. However, dynamic and non-invasive quantitative assessment of melanin distribution remains difficult with traditional histological methods. Methods: In this study, an AI-assisted objective evaluation framework was established for three-dimensional pigmented epidermis-on-a-chip models based on brightfield images. Melanin regions were segmented using the MEM-ViT algorithm, and their morphological features were extracted to build a multi-indicator comprehensive analysis system for determining the “good/poor” status of the model. Results: The results showed 98% consistency between algorithmic predictions and manual annotations, demonstrating the reliability and generalization capability of the proposed method. The framework enabled accurate segmentation of melanin regions and standardized evaluation of model quality without staining. Discussion: This method provides a rapid, non-invasive, and standardized approach for evaluating 3D pigmented epidermis-on-a-chip models. It offers a useful technical pathway for drug efficacy research, whitening mechanism analysis, and objective assessment of skin pigmentation-related disorders.

Verified
Journal Article
Open access
PDF file
HLHuan Lian
Huan Lian
YLYu Liu
Yu Liu
LKLinnan Ke
Linnan Ke
QHQianqian Han
Qianqian Han
Immunotoxicity evaluation has been crucial in preclinical testing for implantable animal-derived biomaterials due to their prolonged contact with the human body, which requires stringent safety assessments. By creating experimental models with varying levels of immunotoxicity, this study reveals the decisive role of decellularization treatment in diminishing the immunogenicity of materials, thus ensuring clinical safety. Employing cutting-edge differential gene expression analysis, the research not only accurately quantifies gene expression alterations in immune responses but also, through pathway enrichment analysis, identifies gene networks associated with oncogenesis. This offers novel insights into the mechanisms of immune responses following biomaterial implantation. Additionally, the study highlights the importance of developing highly sensitive immunotoxicity testing methods and validates the efficacy of high-throughput sequencing and bioinformatics tools in assessing biomaterial safety, providing robust scientific support for future preclinical evaluations.

17 May 2026 in Journal of Controlled Release
Verified
Journal Article
Closed access
MHMuye He
Muye He
ZXZhenze Xie
Zhenze Xie
LWLing Wang
Ling Wang
CSChengxiao Song
Chengxiao Song
DCDandan Chen
Dandan Chen
CDChang Du
Chang Du

21 September 2026 in Gels
Verified
Journal Article
Open access
PDF file
Shize WuShize Wu
Shize Wu
ZZZixi Zhao
Zixi Zhao
DJDonghe Jia
Donghe Jia
HLHuiying Li
Huiying Li
YHYijing Huang
Yijing Huang
QHQianqian Han
Qianqian Han
Peritoneal adhesions are a common complication following abdominal surgery. Their formation is associated with factors such as inflammatory responses, imbalance in the fibrinolytic system, and proliferation of fibrous tissue. Currently available anti-adhesion products on the market are primarily physical barrier membranes, which have limited functionality, can only serve as passive barriers, and have suboptimal handling and residence times. To address this issue, this study utilized 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride/N-hydroxysuccinimide (EDC/NHS) chemical crosslinking to create polyglutamic acid-polylysine (PGA-PL) hydrogels and tested their anti-adhesion and reparative effects in a cecum–abdominal wall adhesion model in Sprague–Dawley (SD) rats. Experimental results demonstrated that treatment with PGA-PL hydrogels significantly reduced the occurrence of adhesions, effectively decreased inflammatory cell infiltration, neovascularization, and collagen deposition, while exhibiting excellent biocompatibility. Additionally, it markedly reduced the expression of pro-inflammatory factors, transforming growth factor-β1 (TGF-β1), and α-smooth muscle actin (α-SMA) in both serum and local tissue, increased the levels of plasminogen activators, and promoted the proliferation of peritoneal mesothelial cells. PGA-PL hydrogel is a safe and effective anti-adhesion material; its efficacy not only relies on serving as a physical barrier but also actively modulates local inflammatory responses, fibrotic processes, and fibrinolytic balance, while promoting mesothelial repair.